课题基金 / 基金详情

Epidemiology, Prevention and Treatment of Influenza and Other Respiratory Infecti

Epidemiology, Prevention and Treatment of Influenza and Other Respiratory Infecti
流感及其他呼吸道传染病的流行病学、防治
批准号:
8425793
负责人:
William Kwabena Ampofo
金额:
$90.0万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-30 至 2017-09-29

项目摘要

项目成果

William Kwabena Ampofo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Acute lower respiratory infections (ALRI) are a common cause of illness globally and it is estimated to be the third common cause of death, approximately 7% of all deaths in 2004. In Ghana, where infectious diseases including respiratory infections, constitute more than 40% of all deaths in the country, there is little or n data on the epidemiology of ALRI and almost all febrile episodes are treated as malaria. Knowledge of the epidemiology, treatment and prevention of respiratory infections will assist in producing reliable estimates of the burden of ALRI to inform the preparation of national preparedness plans against influenza epidemics. At the core of these studies will be; i) a health facility based prospective surveillance of severe influenza; ii) a cohort of pregnant women and their infants and iii) a cohort of young children to estimate the burden of severe disease in these two groups of persons as a baseline for future vaccine trials. We will use these studies to document among other things the hospitalization rate of severe influenza, the burden of influenza and risk factors for severe influenza in the population, pregnant women and young children as well as evaluate case definitions for influenza and other respiratory pathogens in the DWD. In addition we will characterize influenza and other respiratory pathogens in patients with co-morbid and chronic conditions such as malaria, HIV/AIDs, Tuberculosis and Diabetes. We will also conduct studies on the immune response to influenza virus infection in the population. The studies will be initiated in the Dangme West District, one of the DSS sites in the country, and subsequently transition to the two other demographic surveillance sites in Kintampo and Navrongo in the middle belt and the northern guinea savannah respectively. We hope to obtain comprehensive data on the epidemiology, treatment and prevention of influenza and other respiratory infections in Ghana, including the hospitalization rate of severe influenza, the burden of influenza and risk factors for severe influenza. We will also obtain data to evaluate case definitions for influenza and other respiratory pathogens in the Dodowa district and characterize influenza and other respiratory pathogens in patients with co- morbid and chronic conditions such as HIV/AIDs, Tuberculosis and Diabetes. Taken together, the data from these studies will enable us to determine the relative importance of influenza and other respiratory pathogens as causes of ill health in the country as well as strengthen the capabilities of the Institute to condct training for other sites in the West African sub-region. PUBLIC HEALTH RELEVANCE: Acute lower respiratory infections (ALRI) are a common cause of illness globally and it is estimated that approximately 430 million cases occurred globally in 2004 making it the second most common cause of illness in all age groups. Influenza and other respiratory infections are believed to be the cause of substantial portion of morbidity and mortality in developing countries but there is no specific information on influenza disease burden in sub-Saharan countries including Ghana. The little data available has been gathered from nascent hospital based surveillance for ARI following the pandemic influenza of 2009. Knowledge of the epidemiology, treatment and prevention of respiratory infections will assist in producing reliable estimates of the burden of ALRI to inform the preparation of national preparedness plans against influenza epidemics. We intend to explore a population-based cohort to estimate the incidence of influenza infection in the DWD and a health facility based prospective surveillance to estimate the rate of severe influenza in the community. We will use these studies to document among other things the occurrence of influenza like illness in the population, the hospitalization rate of severe influenza, the burden of influenza and risk factors for severe influenza as well as evaluate case definitions for influenza and other respiratory pathogens in the DWD. In addition we will characterize influenza and other respiratory pathogens in patients with co-morbid and chronic conditions such as HIV/AIDs, Tuberculosis and Diabetes. We will also conduct studies on the immune response to influenza virus infection in the population. The studies will be initiated in the Dangme West District, a district which has one of the Demographic Surveillance Systems is sited in the country and subsequently transitioned to two other demographic surveillance sites in Kintampo and Navrongo in the middle belt and the northern guinea savannah respectively. We hope to obtain comprehensive data on the epidemiology, treatment and prevention of influenza and other respiratory infections in Ghana, including the hospitalization rate of severe influenza, the burden of influenza and risk factors for severe influenza. We will also obtain data to evaluate case definitions for influenza and other respiratory pathogens in the Dodowa district and characterize influenza and other respiratory pathogens in patients with co-morbid and chronic conditions such as HIV/AIDs, Tuberculosis and Diabetes. Taken together, the data from these studies will enable us to determine the relative importance of influenza and other respiratory pathogens as causes of ill health in the country as well as strengthen the capabilities of the Institute to conduct training fr other sites in the West African sub-region.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epidemiology, Prevention and Treatment of Influenza and Other Respiratory Infecti
Epidemiology, Prevention and Treatment of Influenza and Other Respiratory Infecti
Epidemiology, Prevention and Treatment of Influenza and Other Respiratory Infecti
海外基金